General Atlantic Completes Strategic Investment in Synaptive Medical
|Areas||Corporate Finance and Securities, Tax, Technology|
Goodmans represented General Atlantic LLC in connection with its strategic investment in Synaptive Medical, a leading medical device and technology company.
Founded in 2012 and headquartered in Toronto, Synaptive develops integrated technologies to solve challenges both in and beyond the operating room. The company’s BrightMatter™ suite of products provide advanced visual and information tools that allow surgeons to focus on patient outcomes within a global healthcare industry. The company’s surgical technology—which combines informatics, imaging, surgical planning, navigation and advanced optics—has been installed at top-ranked health care facilities across the United States.
General Atlantic LLC - with over 35 years of experience investing in 250 growth companies and deep expertise in the healthcare and technology sectors, General Atlantic partners with entrepreneurs and management teams around the world to help them accelerate growth and become market leaders.